Stamford, CT -- (SBWIRE) -- 12/07/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Geron Corporation (NASDAQ:GERN), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), DryShips Inc. (NASDAQ:DRYS), FuelCell Energy Inc (NASDAQ:FCEL)
Geron Corporation (NASDAQ:GERN) ended lower -0.17% from its previous close of $5.87 and complete the day at $5.86. The total number of shares changed hands during the day was 22.57 million. After opening at $6.72, the stock hit as high as 6.92. However, it traded between $0.98 and $7.79 over the last twelve months. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Has GERN Found The Bottom and Ready To Move Up? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) closed yesterday at $4.07, a -10.94% decrease. Around 20.78 million shares were traded, low from an-average trading volume of 22.93 million shares. The company is now valued at around $755.62 million. The stock opened the session at $4.39 and touched its highest price point at $4.48.
ARIA’s lowest price point for the session stood at $4.01 and its 52 week price range stood at $2.15 - $24.59. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors. Iclusig is a tyrosine kinase inhibitor (TKI) that is approved in the United States for the treatment of adult patients with chronic, accelerated, or blast phase chronic myeloid leukemia, who are resistant or intolerant to prior TKI therapy
Has ARIA Found The Bottom And Ready To Gain Momentum? Find Out Here
DryShips Inc. (NASDAQ:DRYS) moved -2.78 percent lower at $3.50 and traded between $3.48 and $3.70 after opening the day at $3.67. Its performance over the last five days remained 1.74%, which stands at 14.01% for a month. Going back further than one month, 1-year performance after recent close was 118.75%.
The company has a total of 13.92 million outstanding shares and its total market capitalization is $1.41 billion. Its beta value stands at 2.97 times and earnings per share was -$0.83. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. The company, through its majority owned subsidiary, Ocean Rig, owns and operates 10 offshore ultra deepwater drilling units comprising 2 ultra deepwater semisubmersible drilling rigs and 8 ultra deepwater drillships, three of which are scheduled to be delivered to the company during 2013 and one of which is scheduled to be delivered during 2015.
Why Should Investors Buy DRYS After the Recent Fall? Just Go Here and Find Out
FuelCell Energy Inc (NASDAQ:FCEL)’s shares rose, +8.86 percent from its previous close of $1.58 to close at $1.72. The stock is up around 87.57% this year and 100% for the last 12 months. Around 11.81 million shares changed hands yesterday, higher from an-average trading volume of 2.95 million shares. FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation. It offers Direct FuelCell power plants that electrochemically produce electricity and heat using various fuels, including gas, methanol, diesel, biogas, coal gas, coal mine methane, and propane.
Why Should Investors Buy FCEL After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)